SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-23-057682
Filing Date
2023-12-15
Accepted
2023-12-14 17:51:09
Documents
1
Group Members
FRANCESCO MICHELIMATTEO BRUNO RENZULLI

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20016690_sc13g.htm SC 13G 127096
  Complete submission text file 0001140361-23-057682.txt   128730
Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Filed by) CIK: 0001559515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1212
Type: SC 13G

Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Subject) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91007 | Film No.: 231488214
SIC: 2836 Biological Products, (No Diagnostic Substances)